<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05009589</url>
  </required_header>
  <id_info>
    <org_study_id>2021-07</org_study_id>
    <nct_id>NCT05009589</nct_id>
  </id_info>
  <brief_title>HUDDLE: Heart Health: Understanding &amp; Diagnosing Disease by Leveraging Echocardiograms</brief_title>
  <acronym>HUDDLE</acronym>
  <official_title>HUDDLE: Heart Health: Understanding &amp; Diagnosing Disease by Leveraging Echocardiograms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will screen for the presence of cardiovascular disease and provide education about&#xD;
      the signs and symptoms of cardiovascular disease and heart disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">August 7, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Abnormal structural heart findings</measure>
    <time_frame>30 days</time_frame>
    <description>The number of patients with abnormal structural heart findings as identified by echocardiography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Abnormal electrocardiography findings</measure>
    <time_frame>30 days</time_frame>
    <description>The number of patients with abnormal electrocardiography findings such as rhythm disturbances, bundle branch or fascicular block, or other conduction delays</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk factors associated with cardiovascular disease</measure>
    <time_frame>30 days</time_frame>
    <description>Risk factors associated with cardiovascular disease including obesity (BMI and BSA calculations using height and weight, waist circumference) and blood pressure, along with personal and familial medical history.</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Heart Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This study will include participants identified at pre-planned screening events for&#xD;
        cardiovascular disease who provide informed consent.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Key Eligibility Criteria:&#xD;
&#xD;
          1. at least 50 years of age on the day of the screening event&#xD;
&#xD;
          2. informed of the nature of the study, agrees to its provisions, and has provided&#xD;
             written informed consent&#xD;
&#xD;
          3. does not have any conditions that would interfere with obtaining an echocardiogram of&#xD;
             the heart&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>E. Lee Rice, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lifewellness Institute, San Diego, CA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lifewellness Institute</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 4, 2021</study_first_submitted>
  <study_first_submitted_qc>August 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

